OPTICYTE INC
Real-time intracellular oxygen measurement device
- Sector
- Medtech
- Headquarters
- Seattle, WA
- Founded
- 2016
- Latest Form D
- $72K, Oct 2017
- Total capital
- $7.1M
- Federal grants
- $7.1M
- 8 awards · 2015–2022
- Rank in peer group#338 of 538
- Private capital raised
- $72K
- 1 Form D · last Oct 2017
- 109 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 10 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Noninvasive compact device to monitor myoglobin saturation in anemia and critical illness$911K
- Federal grantHealth and Human S · Phase II · Noninvasive compact device to monitor myoglobin saturation in anemia and critical illness$971K
- Federal grantHealth and Human S · Phase II · Noninvasive compact device to monitor myoglobin saturation in anemia and critical illness$2.9M
- Federal grantHealth and Human S · Phase II · Noninvasive compact device to monitor myoglobin saturation in anemia and critical illness$999K
- Private capital raisedForm D · SEC · 1st filing$72K
- Federal grantHealth and Human S · Phase II · Real-time myoglobin saturation measurement to assess benefit of RBC transfusion$500K
- Federal grantHealth and Human S · Phase II · Real-time myoglobin saturation measurement to assess benefit of RBC transfusion$500K
Show 2 earlier federal awards
- Federal grantHealth and Human S · Phase I · Real-time myoglobin saturation measurement to assess benefit of RBC transfusion$150K
- Federal grantHealth and Human S · Phase I · Real-time myoglobin saturation measurement to assess benefit of RBC transfusion$150K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
31months
from OPTICYTE INC’s first federal award to its first private round.
- First federal award · Mar 2015
- Health and Human S · $150K
- First Form D · Oct 2017
- $72K · 1st Form D
- Awards before first raise
- 4 awards
An association in public records, not a cause or a prediction.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Lorilee ArakakiResearcherExecutive Officer, Director, PromoterLinked by $3M in grants as PI
- Kenneth SchenkmanExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Robert MastersonExecutive Officer, Director, PromoterNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 10- PendingDetermining Blood-Oxygen Level (SpO2) Using Broadband Spectra To Reduce Or Eliminate Skin-Tone Bias In The Determined SpO2 Value, And/Or Using Broadband Spectra to Determine Pulse RateUSPTOApplication 18991196
- PendingDetermining A Level Of Oxygenation Of One Or More CellsUSPTOApplication 18821855
- PendingDetermining A Level Of Oxygenation Of One Or More CellsUSPTOApplication 17721167
Show all 10 patent records
- Determining Blood-Oxygen Level (SpO2) Using Broadband Spectra To Reduce Or Eliminate Skin-Tone Bias In The Determined SpO2 Value, And/Or Using Broadband Spectra to Determine Pulse RateApr 30, 2026 · Application 18991196Pending
- Determining A Level Of Oxygenation Of One Or More CellsDec 26, 2024 · Application 18821855Pending
- Determining A Level Of Oxygenation Of One Or More CellsOct 20, 2022 · Application 17721167Pending
- Device And Method For Determining A Level Of Oxygenation In A Cell Such As A Muscle Cell And/or A Blood CellApplication 63508407Pending
- Determining A Level Of Oxygenation Of One Or More CellsApplication PCTUS2022024891Pending
- Determining A Level Of Oxygenation Of One Or More CellsApplication 63176014Pending
- Determining Blood-oxygen Level (spo 2) Using Broadband Spectra To Reduce Or Eliminate Skin-tone Bias In The Determined Spo 2 Value, And/or Using Broadband Spectra To Determine Pulse RateApplication PCTUS2025053182Pending
- Determining A Level Of Oxygenation Of One Or More CellsApplication 19492740Pending
- Determining SPO2 Using Broadband Spectra To Reduce Or Eliminate Skin-Tone Bias In The Determined SPO2 Value, And/Or Determining Pulse Rate Using Broadband SpectraApplication 63713397Pending
- Determining A Level Of Oxygenation Of One Or More CellsApplication PCTUS2024034398Pending
Related companies, and why
- Gravidi, Inc.Similar federal contract value in Medtech · null in contracts
- Enamel Pure Inc.Similar federal contract value in Medtech · null in contracts
- Progenesis Technologies, LLCSimilar federal contract value in Medtech · null in contracts
- Sonablate Corp.Similar federal contract value in Medtech · null in contracts
- ENDOLYNX INCSimilar federal contract value in Medtech · null in contracts
- THIRD COAST DYNAMICS, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .